Involvement of cytochrome P450 and the flavin-containing monooxygenase(s) in the sulphoxidation of simple sulphides in human liver microsomes

Life Sciences

Volumn 73, Issue 3, 2003, Pages 359-369

  Nnane, Ivo P ^a   Damani, Lyaquat A ^b  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chromatography; Sulphide; Sulphoxidation; Sulphoxide

Indexed keywords

4 CHLOROPHENYLMETHYL SULFIDE; CYTOCHROME P450; DIMETHYLANILINE MONOOXYGENASE; ETHYLMETHYL SULFIDE; M PROTEIN; PHENYL SULFIDE; PROADIFEN; SULFIDE; THIAMAZOLE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; CATALYSIS; CHEMICAL ANALYSIS; CHEMICAL REACTION; ENZYME ANALYSIS; HUMAN; LIVER MICROSOME; SULFOXIDATION;

EID: 0038241117     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00290-X     Document Type: Article

References (17)

1. Damani L.A. Sulphur-containing Drugs and related organic compounds. vol. 1:1989;135-150 Ellis Horwood, Chichester.
2. Damani L.A., Nnane I.P. The assessment of the flavin-containing monooxygenase activity in intact animals. Drug Metab. Drug Interact. 13(1):1996;1-28.
3. Hoodi A.A., Damani L.A. Cytochrome P-450 and non-cytochrome P-450 sulphoxidations. J. Pharm. Pharmacol. 36:1984;629. (Suppl).
4. Kedderis G.L., Rickert D.E. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism; Role of flavin-containing monooxygenase. Drug Metab. Dispos. 13:1985;58-61.
5. Kobayashi S., Murray S., Watson D., Sesardic D., Davies D.S., Boobis A.R. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochem Pharmacol. 38(17):1989;2795-2799.
6. Lawton M.P., Cashman J.R., Cresteil T., Dolphin C.T., Elfarra A.A., Hines R.N., Hodgson E., Kimura T., Ozols J., Phillips I.R., Philpot R.M., Poulsen L.L., Rettie A.E., Shepard E.A., Williams D.E., Ziegler D.M. A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities. Arch. Biochem. Biophys. 308:1994;254-257.
7. Madesclaire M. Synthesis of sulfoxides by oxidation of thioethers. Tetrahedron. 42:1986;5459-5495.
8. Murray M. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes. Int. J. Mol. Med. 3:1999;227-238.
9. Murray M., Reidy G.F. Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacol. Rev. 42:1990;85-101.
10. Nelson D.R. Cytochrome P450 and the individuality of species. Arch. Biochem. Biophys. 369:1999;1-10.
11. Nnane I.P., Damani L.A. Metabolism of ethyl methyl sulphide and sulphoxide in rat microsomal fractions. Xenobiotica. 29:1999;1101-1113.
12. Nnane I.P., Damani L.A. HPLC analysis of 4-chlorophenyl methyl sulphide and diphenyl sulphide and their corresponding sulphoxides and sulphones in rat liver microsomes. J. Pharmaceut. Biomed. Analysis. 27:2002;315-325.
13. Otton S.V., Crewe H.K., Lennard M.S., Tucker G.T., Woods H.F. Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes. J. Pharmacol Exp Ther. 247(1):1988;242-247.
14. Ripp S.L., Itagaki K., Philpot R.M., Elfarra A.A. Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes. Drug Metab. Dispos. 27:1999;46-52.
15. Waxman D.J., Light D.R., Walsh C. Chiral sulfoxidations catalyzed by rat liver cytochromes P-450. Biochemistry. 21:1982;2499-2507.
16. Ziegler D.M. Flavin-containing monooxygenases: enzymes adapted for multisubstrate specificities. TIPS. 11:1990;321-324.
17. Ziegler D.M. Bioactivation of xenobiotics by flavin-containing monooxygenases. Adv. Exp. Med. Biol. 283:1991;41-50.